Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 1 |
| Since 2006 (last 20 years) | 2 |
Descriptor
| Behavior Change | 2 |
| Check Lists | 2 |
| Adolescents | 1 |
| Adults | 1 |
| Autism | 1 |
| Behavior Problems | 1 |
| Children | 1 |
| Comorbidity | 1 |
| Control Groups | 1 |
| Depression (Psychology) | 1 |
| Drug Therapy | 1 |
| More ▼ | |
Author
| Aman, Michael | 1 |
| Boyle, Bailey | 1 |
| Griffith, Gabrielle | 1 |
| Hillring, Sara | 1 |
| Hough, David | 1 |
| Karcher, Keith | 1 |
| Kent, Justine M. | 1 |
| Kushner, Stuart | 1 |
| Ness, Seth | 1 |
| Ning, Xiaoping | 1 |
| Piersma, Drew | 1 |
| More ▼ | |
Publication Type
| Journal Articles | 2 |
| Reports - Research | 2 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
| Aberrant Behavior Checklist | 2 |
| Obsessive Compulsive Scale | 1 |
What Works Clearinghouse Rating
Peer reviewed
Direct linkValdovinos, Maria G.; Seibert, Haley N.; Piersma, Drew; Wilkinson, Alyssa; Griffith, Gabrielle; Hillring, Sara; Boyle, Bailey – Journal of Mental Health Research in Intellectual Disabilities, 2019
Introduction: The purpose of this study was to gain additional insight on patterns of behavior of three individuals dually diagnosed with intellectual disability (ID) and bipolar disorder as they cycled between elevated and depressed mood states. Methods: Data were collected from weekly, one-hour observations across a period of several months. The…
Descriptors: Psychological Patterns, Mental Disorders, Intellectual Disability, Comorbidity
Kent, Justine M.; Kushner, Stuart; Ning, Xiaoping; Karcher, Keith; Ness, Seth; Aman, Michael; Singh, Jaskaran; Hough, David – Journal of Autism and Developmental Disorders, 2013
Efficacy and safety of 2 risperidone doses were evaluated in children and adolescents with autism. Patients (N = 96; 5-17 years), received risperidone (low-dose: 0.125 mg/day [20 to <45 kg], 0.175 mg/day [>45 kg] or high-dose: 1.25 mg/day [20 to <45 kg], 1.75 mg/day [>45 kg]) or placebo. Mean baseline (range 27-29) to endpoint change…
Descriptors: Drug Therapy, Children, Adolescents, Autism
